CI Synergy American Fund

Series P USD
 

Fund overview

This fund invests primarily in equity and equity-related securities of companies which are located in countries that have signed the North American Free Trade Agreement (NAFTA) (or its successor).

Fund details

description of elementelement value
Inception date May 2017
CAD Total net assets ($CAD)
As at 2026-10-30
$114.6 million
NAVPS
As at 2026-11-18
$24.7731
MER (%)
As at 2026-03-31
0.24
Management fee (%) 1.00
Units outstanding
As at
-
Asset class U.S. Equity
Currency USD
Minimum investment $500 initial/$25 additional

Risk rating1

  • Low
  • Low to medium
  • Medium
  • Medium to high
  • High

FUND CODES

P 90482
A ISC 545
DSC SO* 548
LL SO 1548
F 507
*No new purchases directly into switch only funds.

Performance2 As at 2026-10-31

Growth of $10,000 (Since inception date)

growth of 10k graph

Calendar year performance

annual performance graph

average annual compound returns

YTD 1 Mo 3 Mo 6 Mo 1 Y 3 Y 5 Y 10 Y Inception*
10.00% -4.25% 1.96% 11.88% 9.77% 22.35% 11.01% - 14.21%
*Since inception date

Management team

First we'll display the Team Company and then the Team members
Jeremy Rosa
Aubrey Hearn

CI Synergy American Fund

Series P USD
 
Portfolio allocations3 As at 2026-10-31
Asset allocation (%)
  • US Equity 92.77
  • International Equity 6.73
  • Canadian Equity 0.44
  • Cash and Equivalents 0.08
  • Other -0.02
Sector allocation (%)
  • Technology 53.96
  • Healthcare 32.26
  • Consumer Services 8.45
  • Financial Services 5.27
  • Cash and Cash Equivalent 0.08
  • Other -0.02
Geographic allocation(%)
  • United States 92.75
  • Taiwan 2.01
  • Netherlands 1.97
  • United Kingdom 1.73
  • Ireland 1.02
  • Canada 0.54
  • Other -0.02
Top holdings5
Sector (%)
1. NVIDIA Corp Computer Electronics 10.59%
2. Microsoft Corp Information Technology 6.54%
3. Amazon.com Inc Retail 5.92%
4. Meta Platforms Inc Cl A Information Technology 4.93%
5. Alphabet Inc Cl C Information Technology 4.77%
6. Thermo Fisher Scientific Inc Healthcare Equipment 4.42%
7. Eli Lilly and Co Drugs 3.72%
8. Apple Inc Computer Electronics 3.59%
9. Abbott Laboratories Healthcare Equipment 3.11%
10. Danaher Corp Healthcare Equipment 3.00%
11. Merck & Co Inc Drugs 2.99%
12. Broadcom Inc Computer Electronics 2.78%
13. Gilead Sciences Inc Drugs 2.69%
14. DexCom Inc Healthcare Equipment 2.44%
15. Johnson & Johnson Drugs 2.14%
Over 35,000 financial advisors have chosen CI Global Asset Management as a partner. We believe that Canadians have the best opportunity for investments success by using the services of a professional financial advisor. Learn more at ci.com.